Cargando…

Global Trends in Mortality and Burden of Stroke Attributable to Lead Exposure From 1990 to 2019

BACKGROUND: Lead exposure is an important risk factor for stroke. However, the latest global spatiotemporal patterns of lead exposure-related stroke burden were unclear. In this study, we assessed this topic. METHODS: The data were obtained from the Global Burden of Disease Study (2019). The estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tongchao, Yin, Xiaolin, Zhang, Yuan, Chen, Hui, Man, Jinyu, Li, Yufei, Chen, Jiaqi, Yang, Xiaorong, Lu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259800/
https://www.ncbi.nlm.nih.gov/pubmed/35811690
http://dx.doi.org/10.3389/fcvm.2022.870747
Descripción
Sumario:BACKGROUND: Lead exposure is an important risk factor for stroke. However, the latest global spatiotemporal patterns of lead exposure-related stroke burden were unclear. In this study, we assessed this topic. METHODS: The data were obtained from the Global Burden of Disease Study (2019). The estimated annual percentage change (EAPC) was estimated to evaluate the temporal trends of the age-standardized mortality and disability-adjusted life years (DALYs) rates (ASMR and ASDR) of stroke attributable to lead exposure. RESULTS: In 2019, the numbers of global stroke deaths and DALYs attributable to lead exposure were 305.27 and 6738.78 thousand, respectively. The corresponding ASMR and ASDR were highest in males, the elderly population, low and middle-income countries, and the intracerebral hemorrhage subtype. From 1990 to 2019, the ASMR and ASDR of global stroke attributable to lead exposure decreased [ASMR: EAPC = −1.34, 95% confidence interval (CI): (−1.57, −1.10); ASDR: EAPC = −1.74, 95% CI: (−1.95, −1.52)], especially in females, the high-income countries, and the subarachnoid hemorrhage subtype. CONCLUSION: This study emphasizes the importance of continued implementation of lead exposure prevention strategies and improved high-efficiency treatment and stroke acute health care, especially in low and middle-income countries.